Last reviewed: June 12, 2026
Last updated: June 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed weight loss outcomes, but pregnancy planning requires intentional timing. Current evidence suggests stopping GLP-1 therapy 2–3 months before attempting conception, though individual timelines depend on your health profile, dose history, and fertility goals.
GLP-1 Medications and Pregnancy: What the Evidence Shows
Animal reproduction studies on semaglutide and tirzepatide have not shown direct fetal harm at therapeutic doses, but human pregnancy data remains limited because these drugs were developed for diabetes and weight management in non-pregnant populations. The U.S. FDA categorizes both compounds as Category C for pregnancy, meaning risk cannot be ruled out. Most reproductive endocrinologists and maternal-fetal medicine specialists recommend discontinuing GLP-1 therapy before conception as a precautionary measure, even though serious adverse outcomes have not been documented in limited human case reports.
Placental transfer of GLP-1 agonists occurs at low levels, but the long-term effects on fetal development, pancreatic function, and metabolic programming remain unstudied. Because weight loss medications are not essential for fetal survival (unlike insulin in type 2 diabetes during pregnancy), the risk-benefit analysis favors discontinuation rather than continuation during the nine-month gestation period and postpartum window.
When to Stop GLP-1 Therapy: The 8–12 Week Window
Most fertility specialists recommend stopping GLP-1 injections or oral medications 8–12 weeks (roughly 2–3 months) before planned conception attempts. This timeline allows the medication to clear your system, your appetite hormones to normalize, and your metabolism to stabilize before pregnancy occurs. For semaglutide, which has a half-life of 7 days, clearance from the body takes approximately 4–5 weeks; tirzepatide, with a half-life of 5 days, clears in roughly 3–4 weeks. Adding 4–8 additional weeks ensures hormonal equilibrium and allows your healthcare provider to establish a new baseline for nutritional intake and weight management.
If you are using PlexusDx compounded semaglutide injection or tirzepatide injection, schedule a consultation with your prescribing physician at least three months before your planned conception date. This advance planning allows time to document your current weight, metabolic markers, and any GLP-1–related side effects that may rebound after discontinuation, such as increased appetite or slight weight regain.
Managing Weight and Metabolism Between GLP-1 Discontinuation and Pregnancy
Stopping GLP-1 therapy often triggers appetite rebound and may result in 5–15% weight regain in the months following discontinuation, depending on your dietary habits and physical activity. To minimize this rebound and support fertility health, shift focus to sustainable nutrition strategies: increase whole-grain carbohydrates, protein intake, and fiber from vegetables and legumes; reduce ultra-processed foods; and maintain consistent exercise (150+ minutes of moderate aerobic activity weekly). These behavioral adjustments preserve the metabolic gains achieved during GLP-1 treatment while preparing your body for the nutritional demands of pregnancy.
Vitamin and micronutrient status becomes especially important during this transition window. GLP-1 medications can reduce overall calorie intake and may lower absorption of vitamin B12, calcium, and iron—all critical for fertility and early pregnancy. Work with your healthcare provider or a registered dietitian to assess and optimize these micronutrients at least 4–6 weeks before conception attempts.
Postpartum GLP-1 Therapy: When and How to Restart
Most medical guidelines advise waiting until breastfeeding is complete before restarting GLP-1 medications, because these compounds can pass into breast milk at low levels and effects on infant development are unknown. If you plan to formula-feed, you may restart GLP-1 therapy at 6–8 weeks postpartum after clearance from your obstetrician. If breastfeeding, postpone GLP-1 restart until weaning is complete, which typically occurs between 6–12 months postpartum. This timeline balances your postpartum health and weight management needs against infant safety.
When you return to PlexusDx semaglutide injection (starting at $149/month) or another GLP-1 therapy after pregnancy, your prescribing provider will likely restart at a lower dose than your pre-pregnancy level, as your insulin sensitivity and appetite hormones may have shifted during pregnancy and lactation. Consider adding the Precision Peptide Genetic Test ($99 after first month of treatment) to your postpartum plan—this peptide-pathway analysis maps 14 metabolic pathways and 49 peptides to identify which GLP-1 approach may work best for your genetic predispositions as you restart therapy.
Medical Support: Partner With Your Fertility and Primary Care Teams
Stopping GLP-1 therapy is not a solo decision; it requires coordination between your weight-loss provider (who prescribed your PlexusDx medication), your primary care physician, and your fertility specialist or obstetrician. Provide each team member with a complete medication history, including your GLP-1 dose schedule and any concurrent medications or supplements. This integrated approach ensures that your discontinuation plan aligns with your fertility timeline, any underlying metabolic conditions (such as polycystic ovary syndrome or type 2 diabetes), and your postpartum health goals.
PlexusDx supports this collaborative care by providing detailed medication records and dose escalation history to your healthcare team upon request. All PlexusDx medications are compounded by licensed 503A pharmacies and come with full documentation, making it easy to share your treatment history with your fertility and prenatal care providers.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long does it take for semaglutide or tirzepatide to leave my body before pregnancy?
Semaglutide clears in approximately 4–5 weeks due to its 7-day half-life, while tirzepatide clears in 3–4 weeks with a 5-day half-life. However, reproductive endocrinologists recommend stopping 8–12 weeks before conception to allow hormonal normalization and appetite regulation to stabilize, rather than relying on pharmacokinetic clearance alone.
Is it safe to stay on GLP-1 medication during pregnancy?
Current evidence does not show direct fetal harm from semaglutide or tirzepatide in limited human data, but both are FDA Category C for pregnancy. Because GLP-1 drugs are not essential for pregnancy health and human reproductive safety data is limited, most maternal-fetal medicine specialists recommend discontinuation before conception as a precautionary approach.
Will I regain weight after stopping my GLP-1 injection or oral medication?
Weight rebound of 5–15% is common after GLP-1 discontinuation due to appetite normalization. Minimize this by maintaining consistent exercise, increasing protein and fiber intake, and eliminating ultra-processed foods during your 2–3 month discontinuation window before conception.
Can I breastfeed while taking GLP-1 medications?
GLP-1 agonists pass into breast milk at low levels, and infant safety data is lacking. Most lactation and obstetric guidelines recommend completing breastfeeding (typically 6–12 months) before restarting GLP-1 therapy. If you plan to formula-feed, you may restart at 6–8 weeks postpartum with your physician's approval.
What is the PlexusDx Precision Peptide Genetic Test and how does it help after pregnancy?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 49 peptides using genetic markers like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 to predict your individual response to GLP-1 therapy. When you restart PlexusDx semaglutide injection (from $149/month) postpartum, this test guides personalized dose selection and compound choice for optimal results.
How much does PlexusDx semaglutide cost, and will my insurance cover it if I'm planning pregnancy?
PlexusDx compounded semaglutide injection starts at $149/month and is available in all 50 states without insurance—your dose may need to go up, but your price won't. Before pregnancy, you may use HSA/FSA funds to cover your therapy. Postpartum coverage and insurance eligibility should be confirmed with your health plan during pregnancy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Tirzepatide While Breastfeeding? What You Need to Know
Can You Get Ozempic Online? What You Need to Know About Safe Access and Weight Loss Support